In what may be the largest study of sleep problems among individuals with multiple sclerosis (MS), researchers at UC Davis have found that widely undiagnosed sleep disorders may be at the root of the most common and disabling ...
Sep 12, 2014
0
0
During a 10-year period, there were 1,580 adverse drug events reported in the United States and 21 other countries that indicated impulse control disorders in patients, including 628 cases of pathological gambling, 465 cases ...
Oct 20, 2014
0
0
A protein profile of people with restless leg syndrome (RLS), identifies factors behind disrupted sleep, cardiovascular dysfunction and pain finds research in BioMed Central's open access journal Fluids and Barriers of the ...
Jun 6, 2013
0
0
In a new Annals 'Beyond the Guidelines,' a clinical psychologist and sleep physician debate the management of a patient with chronic insomnia who has been treated with medications. All 'Beyond the Guidelines' features are ...
Dec 13, 2022
0
9
There is growing evidence that sleep disorders like insomnia and sleep apnea are related to stroke risk and recovery from stroke, according to a recent literature review. The review is published in the August 3, 2016, online ...
Aug 3, 2016
0
2
(HealthDay)—Research has long shown how psychological disorders lead to poor physical health. Now scientists are learning more about the flip side of emotions, how living a purposeful life may have as many physical benefits ...
Oct 18, 2019
0
9
About one in three adults in the United States report routinely not getting enough sleep. Sleep insufficiency is associated with increased risk for diabetes, cardiovascular disease, mental health problems, injuries, loss ...
Jan 11, 2023
0
21
Long-term off-label use of quinine, still prescribed to individuals with muscle cramps despite Food and Drug Administration warnings of adverse events, is associated with an increased risk of death, according to a study published ...
May 9, 2017
0
0
A drug commonly used to treat pain, epilepsy, anxiety and other brain health disorders may be associated with an increased risk of major birth defects, according to a study published in the May 18, 2016, online issue of Neurology, ...
May 18, 2016
0
7
(HealthDay) -- The Neupro (rotigotine) transdermal system has been approved by the U.S. Food and Drug Administration to treat advanced Parkinson's disease and moderate-to-severe restless leg syndrome, the Belgian drug maker ...
Apr 3, 2012
0
0
